Matrix metalloproteinase inhibition blocks progression of heart failure

被引:0
|
作者
Peterson, JT [1 ]
Rosebury, WS [1 ]
Robertson, AW [1 ]
Washington, RA [1 ]
Li, H [1 ]
OBrien, PM [1 ]
Sliskovic, DR [1 ]
Hallak, H [1 ]
Uprichard, ACG [1 ]
Bocan, TMA [1 ]
机构
[1] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,ANN ARBOR,MI 48105
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2916 / 2916
页数:1
相关论文
共 50 条
  • [1] Matrix metalloproteinase inhibition and the prevention of heart failure
    Lee, RT
    TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (05) : 202 - 205
  • [2] Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure
    Morita, Hideaki
    Khanal, Sanjaya
    Rastogi, Sharad
    Suzuki, George
    Imai, Makoto
    Todor, Anastassia
    Sharov, Victor G.
    Goldstein, Sidney
    O'Neill, Timothy P.
    Sabbah, Hani N.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (06): : H2522 - H2527
  • [3] Matrix metalloproteinase therapy in heart failure
    Spinale F.G.
    Wilbur N.M.
    Current Treatment Options in Cardiovascular Medicine, 2009, 11 (4) : 339 - 346
  • [4] Inhibition of Membrane-Type 1 Matrix Metalloproteinase Tyrosine Phosphorylation Blocks Tumor Progression in Mice
    Nyalendo, Carine
    Sartelet, Herve
    Gingras, Denis
    Beliveau, Richard
    ANTICANCER RESEARCH, 2010, 30 (06) : 1887 - 1895
  • [5] Matrix metalloproteinase inhibitor, PD 166793, alters progression of heart failure in the myocardial infarcted
    Peterson, T
    Sanchez, B
    Robertson, A
    Rosebury, W
    Bryant, JW
    Dillon, L
    Hallak, H
    Johnson, L
    Bocan, TMA
    CIRCULATION, 1998, 98 (17) : 418 - 418
  • [6] Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure?
    Creemers, EEJM
    Cleutjens, JPM
    Smits, JFM
    Daemen, MJAP
    CIRCULATION RESEARCH, 2001, 89 (03) : 201 - 210
  • [7] Matrix Metalloproteinase-13 Inhibition is Protective in a Pressure Overload Model of Heart Failure
    Schafer, Allison E.
    Valiente-Alandi, Inigo
    Blaxall, Burns C.
    CIRCULATION RESEARCH, 2016, 119
  • [8] Matrix Metalloproteinase-13 Inhibition is Protective in a Pressure Overload Model of Heart Failure
    Schafer, Allison
    Vallente-Alandi, Inigo
    Blaxall, Burns C.
    FASEB JOURNAL, 2016, 30
  • [9] Selective matrix metalloproteinase inhibition with developing heart failure - Effects on left ventricular function and structure
    King, MK
    Coker, ML
    Goldberg, A
    McElmurray, JH
    Gunasinghe, HR
    Mukherjee, R
    Zile, MR
    O'Neill, TP
    Spinale, FG
    CIRCULATION RESEARCH, 2003, 92 (02) : 177 - 185
  • [10] Matrix metalloproteinase inhibition with congestive heart failure improves left ventricular geometry and pump function
    Spinale, FG
    Krombach, RS
    Coker, ML
    Mukherjee, R
    Houck, WV
    Clair, MJ
    Kribbs, SB
    Hebbar, L
    Peterson, JT
    CIRCULATION, 1997, 96 (08) : 2915 - 2915